Biologic Drugs With Mechanism of Action: Vascular Endothelial Growth Factor Inhibitors
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Vascular Endothelial Growth Factor Inhibitors
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | ⤷ Get Started Free | ⤷ Get Started Free |
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | ⤷ Get Started Free | ⤷ Get Started Free |
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | ⤷ Get Started Free | ⤷ Get Started Free |
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | ⤷ Get Started Free | ⤷ Get Started Free |
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 2004-02-26 | ⤷ Get Started Free | ⤷ Get Started Free |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
